Samuels, A. M., Ansong, D., Kariuki, S. K., Adjei, S., Bollaerts, A., Ockenhouse, C., Westercamp, N., Lee, C. K., Schuerman, L., Bii, D. K., Osei-Tutu, L., Oneko, M., Lievens, M., Attobrah Sarfo, M. A., Atieno, C., Morelle, D., Bakari, A., Sang, T., Jongert, E., Kotoh-Mortty, M. F., Otieno, K., Roman, F., Buabeng, P. B. Y., Ntiamoah, Y., Ofori-Anyinam, O., Agbenyega, T., , , Sambian, D., Agordo Dornudo, A., Nana Badu, L., Akoi, K., Antwi, E., Onoka, K., K'Orimba, K., Ndaya Oloo, P., Leakey, E., Gvozdenovic, E., Cravcenco, C., Vandoolaeghe, P., Vekemans, J., & Ivinson, K. (2022). efficacy of RTS, S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial. Lancet infectious diseases, 22(9), 1329–1342. http://access.bl.uk/ark:/81055/vdc_100163055692.0x000017